Is it necessary for a drug to cross blood-brain-barrier to be effective in multiple sclerosis or EAE?

Among the drugs used for MS, few like IFN-beta, Natalizumab, Glatiramer acetate don't cross BBB while Fingolimod do. So a humble request to the experts for their comments.

07 December 2016 8,116 5 View